Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Francesco Facchinetti, M.D., Ph.D.

Concepts (186)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Non-Small-Cell Lung44202453894.370 Why?
Lung Neoplasms512024134513.370 Why?
Protein Kinase Inhibitors18202456961.670 Why?
Drug Resistance, Neoplasm13202453371.550 Why?
Lactams, Macrocyclic520193181.450 Why?
Sulfones420184471.140 Why?
Pyrazoles8202420330.950 Why?
Immunotherapy10202447520.910 Why?
Cholangiocarcinoma320245780.870 Why?
Protein-Tyrosine Kinases7202124230.860 Why?
Receptor, Fibroblast Growth Factor, Type 2120242200.840 Why?
Antineoplastic Agents112020136480.760 Why?
Lactams620211590.760 Why?
Pyrimidines7202430470.760 Why?
Mutation182024301980.750 Why?
Proto-Oncogene Proteins7202145200.690 Why?
Receptor Protein-Tyrosine Kinases4202116240.680 Why?
Receptors, Fibroblast Growth Factor120191920.630 Why?
MAP Kinase Kinase Kinases120202520.620 Why?
Acrylamides320222570.610 Why?
Aminopyridines620215760.610 Why?
Thoracic Neoplasms220212670.600 Why?
Xenograft Model Antitumor Assays3202436080.570 Why?
Hemoptysis120191500.570 Why?
Immunomodulation120215470.570 Why?
Carcinoma, Transitional Cell120237900.530 Why?
Pyridines3201728880.530 Why?
Pleural Neoplasms220235810.520 Why?
Proto-Oncogene Proteins B-raf5202420540.500 Why?
Mesothelioma220237710.480 Why?
Aniline Compounds3202210750.470 Why?
Gene Rearrangement7202111440.430 Why?
Tachyphylaxis12013540.430 Why?
Intestinal Diseases120185060.430 Why?
Phosphopyruvate Hydratase120131270.420 Why?
Bile Duct Neoplasms320246260.420 Why?
Small Cell Lung Carcinoma220194510.410 Why?
Sarcoidosis120185320.410 Why?
Liver Diseases1202113030.390 Why?
Translocation, Genetic2202113940.390 Why?
Central Nervous System1201813410.370 Why?
Urinary Bladder Neoplasms1202321760.360 Why?
Prognosis162022299220.340 Why?
Tumor Microenvironment1202139460.300 Why?
Medical Oncology1201923390.280 Why?
Humans6520247659680.270 Why?
Patient Selection1201842550.260 Why?
Receptors, Cell Surface1201528170.250 Why?
Liver1202175620.240 Why?
Cell Transformation, Neoplastic1201328440.220 Why?
Antineoplastic Combined Chemotherapy Protocols42023118680.210 Why?
Quinoxalines120242960.200 Why?
Molecular Targeted Therapy4202428220.190 Why?
Antibodies, Monoclonal1201892490.190 Why?
Morpholines120245770.190 Why?
Biliary Tract Neoplasms120221860.170 Why?
Receptors, OX4012020460.170 Why?
Italy220198540.170 Why?
Thymus Neoplasms120222700.170 Why?
Male2520243636980.170 Why?
Survival Analysis42024100700.170 Why?
Neoplasm Metastasis4201848930.160 Why?
Middle Aged2020242230090.160 Why?
Treatment Outcome122024651880.160 Why?
Killer Cells, Natural2201822100.160 Why?
Class I Phosphatidylinositol 3-Kinases120239040.160 Why?
Neoplasm Staging52024112060.160 Why?
Disease Progression52020136320.160 Why?
Female2620243961120.160 Why?
Tumor Escape120213710.150 Why?
Neoplasms, Glandular and Epithelial120224880.150 Why?
Pyrroles1202411190.150 Why?
Indazoles220173030.150 Why?
Aged1620241711170.150 Why?
Portal Vein120214350.150 Why?
BRCA1 Protein1202411530.140 Why?
Pneumonectomy1202411280.140 Why?
Neoplasms32024223400.140 Why?
Lymphocyte Subsets120183150.140 Why?
Proto-Oncogene Proteins p21(ras)3202217610.140 Why?
HLA-A2 Antigen120172070.140 Why?
Oncogene Fusion12017840.140 Why?
Patients120239100.140 Why?
Intubation, Gastrointestinal120181670.130 Why?
Cell Line, Tumor32024170750.130 Why?
Adenocarcinoma1201363640.130 Why?
Germ-Line Mutation1202418840.130 Why?
Exons2202223910.120 Why?
Antifibrinolytic Agents120192850.120 Why?
Clinical Trials, Phase III as Topic120198780.120 Why?
Membrane Proteins3202178510.120 Why?
DNA, Neoplasm1202017420.120 Why?
Disease Susceptibility1202117890.120 Why?
TOR Serine-Threonine Kinases1202320560.110 Why?
Diagnosis, Differential22021129760.110 Why?
Aged, 80 and over102024594890.110 Why?
Salvage Therapy1202112720.110 Why?
Leukocyte Count1201816020.110 Why?
Fatal Outcome1201918310.110 Why?
Phosphatidylinositol 3-Kinases1202328780.110 Why?
Anilides120174150.110 Why?
Drug Substitution120162920.110 Why?
Clinical Trials as Topic2201980410.110 Why?
Adult1620242230440.100 Why?
Oncogene Proteins, Fusion2202116080.100 Why?
Molecular Diagnostic Techniques120176180.100 Why?
Randomized Controlled Trials as Topic22019103830.100 Why?
Quinazolines2201713640.100 Why?
Enteral Nutrition120188030.090 Why?
Drug Therapy, Combination2201963090.090 Why?
Benzamides1201713770.090 Why?
Disease-Free Survival3201968320.090 Why?
Neoplasm Recurrence, Local3202493730.090 Why?
Disease Management1202125350.090 Why?
Energy Metabolism1202128920.090 Why?
Kaplan-Meier Estimate2201764990.080 Why?
Osteoblasts1201511430.080 Why?
Carcinoma, Renal Cell2201631810.080 Why?
Prospective Studies52021548020.080 Why?
Intracellular Signaling Peptides and Proteins1201928800.080 Why?
Signal Transduction32021236010.080 Why?
Lung Diseases, Interstitial120179390.080 Why?
Retrospective Studies82022815140.080 Why?
Angiogenesis Inhibitors2201620560.080 Why?
Kidney Neoplasms2201642740.070 Why?
Bone Neoplasms1202025670.070 Why?
Mice, SCID2202426300.070 Why?
Piperazines1201725490.070 Why?
Anti-Bacterial Agents2202274780.060 Why?
Venous Thromboembolism1201918820.060 Why?
Sulfonamides1201619840.060 Why?
Pneumonia1201721570.060 Why?
Health Personnel1201933900.060 Why?
Gene Expression Regulation, Neoplastic1202186110.060 Why?
Early Detection of Cancer2202132360.060 Why?
CD8-Positive T-Lymphocytes1201846420.060 Why?
Animals420241687640.060 Why?
Follow-Up Studies32020391930.060 Why?
Rad51 Recombinase120241910.050 Why?
Kidney Failure, Chronic1201624950.050 Why?
Immunohistochemistry12016110220.050 Why?
Mice32024818190.050 Why?
Platinum120222180.050 Why?
Thymoma120221850.050 Why?
Clinical Trials, Phase I as Topic120223300.050 Why?
High-Throughput Nucleotide Sequencing2202436550.040 Why?
Calmodulin-Binding Proteins120212370.040 Why?
Clinical Trials, Phase II as Topic120226390.040 Why?
Benzodiazepinones12019500.040 Why?
Neurofibromin 2120192680.040 Why?
Betamethasone12017480.040 Why?
Microtubule-Associated Proteins1202210660.030 Why?
Organophosphorus Compounds120172090.030 Why?
Ligands1202332730.030 Why?
Tomography, X-Ray Computed22016206590.030 Why?
Mice, Inbred NOD1201918370.030 Why?
In Situ Hybridization, Fluorescence1202125050.030 Why?
Half-Life120166440.030 Why?
Epithelial-Mesenchymal Transition120197520.030 Why?
Receptors, Notch120197520.030 Why?
China1202023850.030 Why?
United States Food and Drug Administration1202216720.030 Why?
Withholding Treatment120176210.030 Why?
Lung22021100330.020 Why?
Immunoconjugates120199810.020 Why?
Length of Stay1202464850.020 Why?
Nerve Tissue Proteins1202143920.020 Why?
Young Adult32022598890.020 Why?
Flow Cytometry1201858810.020 Why?
DNA1202272020.020 Why?
Diarrhea1201413160.020 Why?
Renal Dialysis1201617990.020 Why?
Survival Rate12020127950.020 Why?
Body Mass Index12022130390.010 Why?
Receptor, erbB-21201425930.010 Why?
Dose-Response Relationship, Drug12016107290.010 Why?
Longitudinal Studies12019147510.010 Why?
Coronavirus Infections1202031000.010 Why?
Pneumonia, Viral1202032230.010 Why?
Postoperative Complications12024157470.010 Why?
Polymorphism, Single Nucleotide12021160470.010 Why?
Pandemics1202087030.010 Why?
Cytokines1201374210.010 Why?
Cohort Studies12017416490.010 Why?
United States12022729030.010 Why?
Risk Factors12019748400.010 Why?
Facchinetti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (186)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.